Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China
· Delayed Price · Currency is CNY 43.86
+0.19 (0.44%)
Apr 18, 2025, 2:45 PM CST
SHE:300347 Revenue
In the year 2024, Hangzhou Tigermed Consulting had annual revenue of 6.60B CNY, down -10.58%. Hangzhou Tigermed Consulting had revenue of 1.54B in the quarter ending December 31, 2024, a decrease of -11.42%.
Revenue
6.60B
Revenue Growth
-10.58%
P/S Ratio
5.31
Revenue / Employee
648.32K
Employees
10,185
Market Cap
35.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.60B | -780.92M | -10.58% |
| Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
| Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
| Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
| Dec 31, 2020 | 3.19B | 388.97M | 13.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
Hangzhou Tigermed Consulting News
- 8 months ago - Hangzhou Tigermed Consulting reports Q2 results - Seeking Alpha